Product References
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Journal of cellular and molecular medicine
Xia W,Bai H,Deng Y,Yang Y
MA5-26290 was used in Western Blot, Immunohistochemistry to explore the functional role of PLA2G16 in pancreatic adenocarcinoma (PAAD) and the genetic/epigenetic alterations leading to its dysregulation.
Sun Nov 01 00:00:00 UTC 2020
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Journal of cellular and molecular medicine
Xia W,Bai H,Deng Y,Yang Y
MA5-26290 was used in Western Blot, Immunohistochemistry to explore the functional role of PLA2G16 in pancreatic adenocarcinoma (PAAD) and the genetic/epigenetic alterations leading to its dysregulation.
Sun Nov 01 00:00:00 UTC 2020
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Journal of cellular and molecular medicine
Xia W,Bai H,Deng Y,Yang Y
MA5-26290 was used in Western Blot, Immunohistochemistry to explore the functional role of PLA2G16 in pancreatic adenocarcinoma (PAAD) and the genetic/epigenetic alterations leading to its dysregulation.
Sun Nov 01 00:00:00 UTC 2020
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Journal of cellular and molecular medicine
Xia W,Bai H,Deng Y,Yang Y
MA5-26290 was used in Western Blot, Immunohistochemistry to explore the functional role of PLA2G16 in pancreatic adenocarcinoma (PAAD) and the genetic/epigenetic alterations leading to its dysregulation.
Sun Nov 01 00:00:00 UTC 2020